Overview
Venture capital fund investing in early-stage life science companies.
Founded
2018
Deals ยท 12mo
4
Stage focus
Geographic focus
Sector focus
Investment portfolio
| NAME | DATE | SIZE | |
|---|---|---|---|
SyntaxBio | Jun 2026Participated | $14 MSeries A | |
Latus Bio | May 2026Participated | $43 MSeries A | |
Sidewinder Therapeutics | Apr 2026Participated | $137 MSeries B | |
AgZen | Mar 2026Led | $10 MSeries B | |
Nilo Therapeutics | Oct 2025Led | $101 MSeries A | |
Alchemab Therapeutics | Sep 2025Participated | $32 MSeries A | |
Grove Biopharma | Apr 2025Led | $30 MSeries A | |
Solu Therapeutics | Apr 2025Participated | $41 MSeries A | |
Newleos Therapeutics | Feb 2025Participated | $94 MSeries A | |
Umoja Biopharma | Jan 2025Led | $100 MSeries C | |
nChroma Bio | Dec 2024Participated | $75 MOther Equity | |
Latus Bio | May 2024Led | $54 MSeries A | |
SyntaxBio | Jun 2026Participated | $14 MSeries A | |
Latus Bio | May 2026Participated | $43 MSeries A | |
Sidewinder Therapeutics | Apr 2026Participated | $137 MSeries B | |
AgZen | Mar 2026Led | $10 MSeries B | |
Nilo Therapeutics | Oct 2025Led | $101 MSeries A | |
Alchemab Therapeutics | Sep 2025Participated | $32 MSeries A | |
Grove Biopharma | Apr 2025Led | $30 MSeries A | |
Solu Therapeutics | Apr 2025Participated | $41 MSeries A | |
Newleos Therapeutics | Feb 2025Participated | $94 MSeries A | |
Umoja Biopharma | Jan 2025Led | $100 MSeries C | |
nChroma Bio | Dec 2024Participated | $75 MOther Equity | |
Latus Bio | May 2024Led | $54 MSeries A |
Insights
Time horizon
View by
Deal Distribution
| Round type | Led deals | Participated deals |
|---|---|---|
| Seed | 2 | 1 |
| Series A | 16 | 13 |
| Series B | 4 | 6 |
| Series C+ | 1 | 2 |
| Other Equity | 0 | 2 |
Monthly Deal Activity
| Month | Deals |
|---|---|
| Sep '18 | 1 |
| Oct '18 | 0 |
| Nov '18 | 0 |
| Dec '18 | 1 |
| Jan '19 | 0 |
| Feb '19 | 0 |
| Mar '19 | 0 |
| Apr '19 | 0 |
| May '19 | 0 |
| Jun '19 | 1 |
| Jul '19 | 0 |
| Aug '19 | 0 |
| Sep '19 | 0 |
| Oct '19 | 1 |
| Nov '19 | 1 |
| Dec '19 | 0 |
| Jan '20 | 2 |
| Feb '20 | 1 |
| Mar '20 | 0 |
| Apr '20 | 1 |
| May '20 | 0 |
| Jun '20 | 1 |
| Jul '20 | 0 |
| Aug '20 | 0 |
| Sep '20 | 0 |
| Oct '20 | 0 |
| Nov '20 | 1 |
| Dec '20 | 0 |
| Jan '21 | 1 |
| Feb '21 | 0 |
| Mar '21 | 1 |
| Apr '21 | 0 |
| May '21 | 0 |
| Jun '21 | 1 |
| Jul '21 | 1 |
| Aug '21 | 0 |
| Sep '21 | 1 |
| Oct '21 | 1 |
| Nov '21 | 0 |
| Dec '21 | 1 |
| Jan '22 | 0 |
| Feb '22 | 1 |
| Mar '22 | 1 |
| Apr '22 | 2 |
| May '22 | 0 |
| Jun '22 | 0 |
| Jul '22 | 1 |
| Aug '22 | 1 |
| Sep '22 | 1 |
| Oct '22 | 0 |
| Nov '22 | 0 |
| Dec '22 | 1 |
| Jan '23 | 0 |
| Feb '23 | 1 |
| Mar '23 | 1 |
| Apr '23 | 0 |
| May '23 | 1 |
| Jun '23 | 0 |
| Jul '23 | 0 |
| Aug '23 | 2 |
| Sep '23 | 0 |
| Oct '23 | 0 |
| Nov '23 | 0 |
| Dec '23 | 1 |
| Jan '24 | 2 |
| Feb '24 | 1 |
| Mar '24 | 0 |
| Apr '24 | 0 |
| May '24 | 1 |
| Jun '24 | 0 |
| Jul '24 | 0 |
| Aug '24 | 0 |
| Sep '24 | 0 |
| Oct '24 | 0 |
| Nov '24 | 0 |
| Dec '24 | 1 |
| Jan '25 | 1 |
| Feb '25 | 1 |
| Mar '25 | 0 |
| Apr '25 | 2 |
| May '25 | 0 |
| Jun '25 | 0 |
| Jul '25 | 0 |
| Aug '25 | 0 |
| Sep '25 | 1 |
| Oct '25 | 1 |
| Nov '25 | 0 |
| Dec '25 | 0 |
| Jan '26 | 0 |
| Feb '26 | 0 |
| Mar '26 | 1 |
| Apr '26 | 1 |
| May '26 | 1 |
| Jun '26 | 1 |
| Jul '26 | 0 |
| Aug '26 | 0 |
| Sep '26 | 0 |
| Oct '26 | 0 |
Sector Breakdown
A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.
| Sector | Deals |
|---|---|
| Health & Life Sciences | 42 |
| Food & Agriculture | 5 |
| Space & Frontier Tech | 5 |
| Manufacturing | 4 |
| AI & Machine Learning | 4 |
| Consumer & Lifestyle | 4 |
| Developer Tools | 3 |
| Clean Energy & Sustainability | 2 |
| Education & Workforce | 1 |
| Hardware & Robotics | 1 |
| Professional Services | 1 |
| Transportation & Logistics | 1 |
Deal Size Distribution
Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.
| Round size band (USD) | Deals |
|---|---|
| <$5M | 0 |
| $5M-$10M | 1 |
| $10M-$25M | 13 |
| $25M-$50M | 16 |
| $50M-$100M | 9 |
| $100M-$250M | 8 |
| $250M-$500M | 0 |
| $500M-$1B | 0 |
| $1B+ | 0 |
Deals By Geography
Top 3 of 3 regions; European countries are grouped as Europe.
| Region | Deals |
|---|---|
| United States | 42 |
| Europe | 3 |
| Canada | 2 |
Co-Investors
Bubble size = shared deals
Click a bubble to open that fund in a new tab.
Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.
| Co-investor | Shared deals |
|---|---|
| Alexandria Venture Investments | 12 |
| 8VC | 8 |
| Novo Holdings | 6 |
| Casdin Capital | 5 |
| Data Collective | 5 |
| Eli Lilly and Company | 5 |
| 5AM Ventures | 4 |
| Astellas Venture Management | 4 |
| Cormorant Asset Management | 4 |
| Longwood Fund | 4 |
| Lux Capital | 4 |
| MPM Capital | 4 |
| Mubadala Investment Company | 4 |
| RA Capital Management | 4 |
| The Column Group | 4 |
| AgFunder | 3 |
| Deerfield Management | 3 |
| Mubadala Capital | 3 |
| Neotribe Ventures | 3 |
| Qiming Venture Partners USA | 3 |
Investment Strategy
| Category | Deals (count) | Share (%) |
|---|---|---|
| Led | 23 | 49% |
| Participating | 24 | 51% |
| Category | Deals (count) | Share (%) |
|---|---|---|
| Single-lead | 10 | 43% |
| Co-led | 13 | 57% |
Team
Entrepreneur In Residence
Investment Director
Partner
Founder
Partner
Founder